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TO THE EDITOR
Keratitis, ichthyosis, and deafness (KID)
syndrome (OMIM #148210) is a rare
autosomal disorder associating vascu-
larizing keratitis with hyperkeratotic
skin lesions and profound hearing loss.
It is caused by dominant mutations in
the gene GJB2 (OMIM *121011) en-
coding connexin-26 or, more rarely, in
GJB6 (OMIM *604418) encoding con-
nexin-30 (Jan et al, 2004). Connexin-26
is a protein of gap junctions in epithe-
lia, notably of the corneal limbus, the
epidermis, sweat glands and ducts, hair
follicles, and the cochlea. Most cases
are sporadic and arise from a recurrent
missense mutation, c.148G4A (p.As-
p50Asn) (Richard, 2005). We report a
Figure 1. Clinical presentation of the patient and his mother. (a) The proband at birth, showing generalized erythema and scaling, and the absence of scalp hair,
eyebrows, and eyelashes. (b) The proband aged 27 months, showing opaque corneas, total alopecia, and generalized verrucous plaques especially prominent
on the scalp and face. (c and d) Bilateral hyperkeratotic and hyperpigmented lesions along the Blaschko lines on the mother’s chest, shoulders, and back.
Abbreviations: KID, Keratitis-Ichthyosis-Deafness; OMIM, Online Mendelian Inheritance in Man
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severe case of KID syndrome in a child
who inherited this GJB2 mutation from
his mother, who displayed a segmental
form of the disease.
CLINICAL FINDINGS AND
MOLECULAR DIAGNOSIS
This study was approved by the CPP
Toulouse I medical ethics committee,
and conducted according to the princi-
ples of the Declaration of Helsinki. All
clinical samples were obtained with
informed consent.
The proband was a Portuguese boy,
the firstborn of nonconsanguineous
parents, who presented at birth with
generalized erythema, ichthyosiform
scaling, dystrophic nails, and absent
scalp hair, eyebrows, and eyelashes
(Figure 1a). A skin biopsy showed
orthokeratotic hyperkeratosis and
acanthosis. At age 12 months, bilateral
corneal stromal keratitis with vasculariza-
tion and deafness were noted. At age 18
months, he displayed generalized kerato-
tic plaques more prominent on the scalp
and face, where they had a verrucous
appearance (Figure 1b), deep peribuccal
skin grooves, thickening of the skin, and
palmoplantar hyperkeratosis. Total alope-
cia, dystrophic nails, and enamel defects
were noted. Corneal opacification and
photophobia were also observed. The
observed severe global developmental
delay was attributed to early deafness
and near-blindness. Cerebellar vermis
hypoplasia was revealed by nuclear
magnetic resonance imaging, associated
with nystagmus, generalized hypertonia,
and spastic tetraparesia. The patient
suffered from frequent infections of the
skin and oral mucosa and developed
severe malnutrition by age 27 months.
Humoral and cellular immunological
functions were normal.
The father was clinically healthy but
the mother showed low stature and
bilateral, hyperkeratotic, hyperpigmen-
ted, linear cutaneous lesions on the
chest, shoulders, and back along the
Blaschko lines (Figure 1c and d),
suggestive of segmental manifestations
of KID syndrome. Her vision and
hearing were normal. PCR ampli-
fication and direct sequencing of
GJB2 revealed heterozygosity for the
c.148G4A recurrent causative muta-
tion of KID syndrome in the proband’s
leukocyte DNA (Figure 2a), though not
in his parents’ (Figure 2b and c),
confirming the clinical diagnosis of
severe KID syndrome. Cerebellar and
neuromuscular defects, as observed
here, have been reported only in few
cases of this syndrome previously
(Caceres-Rios et al, 1996).
STUDY OF MATERNAL MOSAICISM
The c.148G4A mutation was barely
detectable on the sequence electro-
phoregram in DNA from a lesional
skin biopsy of the mother (Figure 2d),
suggesting its presence in a minority of
cutaneous cells. The mutation was corro-
borated by plasmid cloning of the GJB2
cutaneous PCR amplimer and sequen-
cing of several clones (Figure 2e and f).
This finding and the mother’s circum-
scribed lesions were indicative of mosai-
cism. Lastly, we developed an allele-
specific PCR protocol that selectively
amplified a fragment of the c.148G4A
allele of GJB2 from the proband’s blood
and the maternal lesional skin DNA
(Figure 2g and Supplementary Materials
and Methods), and showed a difference
in signal intensity between the proband
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Figure 2. Identification of the GJB2 mutation. Direct sequence analysis of GJB2 was performed on DNA from peripheral leukocytes of the index patient
(a) and his parents (b and c). The patient’s c.148G4A mutation (arrow) was not observed in his parents’ leukocytes, but was detected on lesional skin DNA
from the mother as a discreet peak on the electrophoregram (d). Individual plasmid clones of the relevant GJB2 amplimer from maternal lesional skin showed
either the wild type (e) or the c.148G4A mutant sequence (f). A PCR specific for the c.148G4A allele amplified a 387 bp GJB2 fragment from the proband’s
blood DNA and maternal DNA from lesional skin, leukocytes, and two primocultures of dermal fibroblasts, but not from the DNA of a healthy control (g).
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and his mother consistent with the
maternal mosaicism detected by DNA
sequencing. Although direct sequencing
failed to detect the mutation in fibroblast
primocultures from maternal lesional
skin, this allele-specific amplification test
did detect the mutant allele in DNA
from these cells and from maternal
leukocytes (Figure 2g).
This is the first example of KID
syndrome inheritance from a proven
mosaic parent displaying lesions con-
sistent with type 1 segmental mani-
festations (Happle, 1997). The localized
epidermal involvement and the pre-
sence of the GJB2 mutation in the
skin indicated maternal mosaicism.
We found the mutation to be present
also in two mesodermal cell types,
leukocytes and dermal fibroblasts.
Although the proportion of mutated
germ cells is unknown, this result
established a risk for the mother to bear
further children with KID syndrome.
DNA-based prenatal diagnosis was
therefore recommended during future
pregnancies.
Molecular evidence of mosaicism
has been provided in the context of
several cutaneous disorders with type 1
or 2 segmental involvement (Happle,
1997). These include epidermolytic
hyperkeratosis (Paller et al, 1994;
Chassaing et al, 2006), neurofibroma-
tosis type 1 (Tinschert et al, 2000),
Darier disease (Sakuntabhai et al,
2000), Hailey-Hailey disease (Poblete-
Gutierrez et al, 2004), and Apert
syndrome (Munro and Wilkie, 1998).
Restano et al. (1999) proposed parental
gonadal mosaicism to explain KID
syndrome in sibling pairs born to
clinically unaffected parents. Recently,
we described brother and sister cases of
KID syndrome with healthy parents
(Mazereeuw-Hautier et al, 2007), and
Jonard et al. (2008) reported a family
with dizygotic twins suffering from a
lethal form of KID. These reports
suggested parental mosaicism but this
could not be formally confirmed.
This case study argues for meticu-
lous clinical assessment of the progeni-
tors to address the origin of a dominant
causative mutation in a patient, and
therefore the need for prenatal diagno-
sis in later pregnancies. Formal diag-
nosis of mosaicism may be difficult if
the mutant allele is near or below the
sensitivity threshold of direct DNA
sequencing in the affected tissue, as
observed here. A mutation identified in
the index case, however, may be
addressed with higher sensitivity in the
progenitors by allele-specific PCR am-
plification (Bottema et al, 1993). In KID
syndrome, where the recurrent muta-
tion c.148G4A accounts for 80% of
cases (Richard, 2005), the allele-speci-
fic amplification we have designed will
be useful to detect this mutation in
parental DNA if mosaicism is sus-
pected. To address the low abundance
of the mutant allele, sensitivity could
be further improved by culturing the
keratinocytes and fibroblasts from le-
sion biopsies, and quantitative real-time
PCR as used by Maertens et al. (2007)
for neurofibromatosis type 1 may be
considered.
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TO THE EDITOR
Despite decades of effort and improved
accuracy of sentinel lymph node detec-
tion, the removal of draining lymph
nodes repeatedly fails to improve mel-
anoma patient mortality (Morton et al.,
2006). The literature is rich with pro
and con arguments regarding the role of
sentinel lymph node biopsy and lymph
node chain removal. The responses to
the article of Morton et al. (A’Hern,
2007; Grichnik, 2007; Kanzler et al.,
2007; Lipsker, 2007; Retsas, 2007;
Thomas, 2007), a commentary by
Gonzales (Gonzalez, 2007) and re-
sponses to that commentary (Cochran
and Thompson, 2008; Morton and
Elashoff, 2008) serve as a window into
this active debate. It is possible that a
different study design or prolonged
follow up will eventually reveal a
survival advantage. It is important to
note the patients with positive sentinel
lymph nodes often receive complete
lymphadenectomy that has significant
morbidity (Guggenheim et al., 2008). It
is also important to note that lympha-
denectomy has thus far failed to im-
prove overall survival in solid tumors
(Gervasoni et al., 2007). However, a
review of these arguments is not the
intent of this paper. Instead the purpose
is to present a hypothesis that may
provide insight into the lack of an
overall survival benefit to lymph node
removal in melanoma patients.
The premise behind sentinel and
lymph node dissections is based on
the assumption that the metastatic cells
enter the lymph system and the lymph
nodes then act as a net capturing the
melanoma cells first in the sentinel
node(s). When the sentinel node fails
to retain all the melanoma cells, then it
is thought that the next node in the
chain will net and hold the released
cancer cells. Certainly an element of
this process is supported by the fact that
with disease progression more lymph
nodes can be found to be involved with
melanoma cells (Morton et al., 2006).
If the premise is correct that lymph
nodes act as a net retaining malignant
melanoma cells, then removal of the
primary and secondary nodes draining
a tumor site should result in a cure as
long as tumor is not found at the end of
the lymph node chain. Unfortunately,
melanoma patients with lymph node
removal still go on to suffer metastatic
disease and die in a similar time frame
to those not undergoing lymph node
removal.
One possible hypothesis is that the
malignant cells merely bypass the
lymph system all together by directly
entering the blood circulatory network.
This is certainly possible given studies
demonstrating direct tumor entry into
the vessels (Warren et al., 1978) and a
correlation of thin melanoma tumor risk
with vascularity (Graham et al., 1994).
However, if the lymph system is the
major mechanism through which tumor
cells leave the primary, then under-
standing the lack of overall survival is
more difficult. Maybe it is due to a
fundamental flaw in our concept of (1)
how lymph nodes function and (2) how
tumors behave.
Hypothesis: A virulent subpopula-
tion of melanoma cells freely traverse
lymph nodes and are subsequently
rapidly disseminated through the vas-
cular system.
HOW DO LYMPH NODES
FUNCTION?
Lymph nodes are perfused by two fluid
channel systems. The first one is a
customary blood circulatory network
with entering arterial and exiting ve-
nous flows. The second is a lymph fluid
channel system entering the node
through afferent vessels and exiting via
efferent vessels (Ohtani et al., 2003).
The blood circulatory network, in
addition to providing for the metabolic
needs of the lymph node, delivers T and
B cells. These cells enter through the
high endothelial vessels, and traverse
nodal tissue (Ohtani et al., 2003). Most
of these cells fail to find an activating
antigen, but rather than leaving the
lymph node via the blood stream they
exit via the efferent lymph system. Cells
that encounter an antigenic target may
locally proliferate but then also leave
via the efferent lymph system. The
number of cells transported back to
the circulatory system from the lymph
nodes has been calculated in the
canine system to be about 245,000
cells per minute per kilogram of weight
(Minnebaev et al., 1981).
Afferent lymph is derived from tissue
fluid and includes essentially any cells,
dissolved or particulate matter that can
be washed into the lymph channel
system. Immune cells that have traveled
into tissue also use the lymph channel
system to return to the circulation. The
afferent lymph vessels enter the lymph
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Why Sentinel Node Fails
